Meet the management of Cellnovo Group SA, a company that develops and distributes the world’s first all-in-one diabetes management system, including a ground-breaking insulin micro-pump. Cellnovo contributes to improving and simplifying the life of diabetic patients and participates in several major projects in the artificial pancreas
Tuesday 30 January 2018,
Hôtel Le NORMANDY, 7 rue de l’Echelle, 75001 Paris
6.45 pm OPENING
7 pm CELLNOVO CONFERENCE
Sophie BARATTE, CEO of Cellnovo
Erwan MARTIN, CFO of Cellnovo
Eric COHEN, President of Agile Capital Markets
– Background
– Team
– Breakthrough innovation, technology
– Market
– Industrial strategy and commercial development
– The artificial pancreas: an opportunity for Cellnovo
– Partnerships and commercial agreements
– Financing and next steps
– Discussions
8-10 pm COCKTAIL
Discussions with management and networking
